Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial

Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial

Abstract Background In patients with chronic obstructive pulmonary disease (COPD), the relationship between short-term bronchodilator reversibility and longer-term response to bronchodilators is unclear. Here, we investigated whether the efficacy of long-acting bronchodilators is associated with rev...

Full description

Bibliographic Details
Main Authors: Claus F. Vogelmeier, Paul W. Jones, Edward M. Kerwin, Isabelle H. Boucot, François Maltais, Lee Tombs, Chris Compton, David A. Lipson, Leif H. Bjermer
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Respiratory Research
Subjects:
Bronchodilator reversibility
COPD
Dual bronchodilators
E-RS
Lung function
Rescue medication
Online Access:https://doi.org/10.1186/s12931-021-01859-w

Internet

https://doi.org/10.1186/s12931-021-01859-w

Similar Items